康龍化成(03759.HK)中期淨利潤增長196.9%至4.79億元 引入逾190家新客户
格隆匯8月26日丨康龍化成(03759.HK)發佈公告,截至2020年6月30日止6個月,公司實現營業收入21.93億元,同比增長34%;歸屬於上市公司股東的淨利潤4.79億元,同比增長196.9%;母公司擁有人應占非國際財務報告準則經調整淨利潤4.32億元,同比增長164.7%;基本每股收益0.6053元。
於報告期間,經營活動所得現金流量淨額約人民幣6.18億元,較截至2019年6月30日止六個月增加約144.9%。
報告期內,公司在2020年上半年引入逾190家新客户,公司龐大、多元化和忠實的重複客户為公司貢獻了90%以上的收入,其中包括全球前二十大醫藥公司。同時,利用長期積累的新藥研發經驗,持續助力中國創新藥研發的發展。2020年上半年為國內醫藥及生物技術公司開展28個研究性新藥IND的申報項目,其中多國(包括中國、美國和歐洲)同時申報的項目20個。
2020年上半年,公司的CMC團隊開展了463個原料藥的完成及在研項目,其中臨牀前項目292個,臨牀一期和二期項目134個,臨牀三期項目35個和商業化階段的項目2個。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.